Actions for Novel Biomarkers in Alzheimer's Disease

Email RIS file
Bookmark
Report an Issue

Novel Biomarkers in Alzheimer's Disease

Published
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
Physical Description
1 online resource (442 p.)
Access Online

Availability

I Want It
I Want It

Finding items...

Language Note
English
Restrictions on Access
Open Access Unrestricted online access
Summary
Alzheimer's disease (AD) represents the most common form of dementia in the elderly population worldwide. AD is characterized by progressive neurodegeneration that leads to a gradual deterioration of memory and other cognitive functions. Given the global prevalence and impact of AD, there is a critical need to establish biomarkers that can be used to detect AD in individuals before the onset of clinical signs and provide mitigating therapeutics. The aim of this Special Issue is to discuss the current knowledge as well as future perspectives on the role of biomarkers in the screening, diagnosis, treatment and follow-up of AD.
Subject(s)
Other Subject(s)
ISBN
9783039439034
9783039439041
books978-3-03943-904-1
Collection
DOAB Library.
Terms of Use and Reproduction
Creative Commons https://creativecommons.org/licenses/by/4.0/
View MARC record | catkey: 33860115